BNTX vs HSIC
BioNTech SE vs Henry Schein — AI-powered side-by-side comparison
| Metric | BNTX | HSIC |
|---|
| AI Score |
66
|
67
|
| Price |
$92.76
|
$89.16
|
| P/E Ratio |
-11.76×
|
25.77×
|
| ROE |
-5.7%
|
12.3%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
68.9%
|
30.3%
|
| Debt / Equity |
0.02×
|
1.21×
|
| Dividend Yield |
0.0%
|
0.0%
|
| RSI (14) |
54.0
|
59.4
|
| Beta |
1.278
|
0.808
|
| Expected Upside |
—
|
+0.8%
|
AI Committee View
Current Innellis committee reasoning for BNTX versus HSIC.
HSIC leads by 1 points.
HSIC scores 67/100 (Buy) versus BNTX at 66/100 (Buy).
BNTX Committee View
50% agreement
4 analysts
The committee is split. Analysts see this stock differently enough that the current rating reflects genuine uncertainty, not a weak signal.
Bull Case
- MACD histogram positive -- bullish momentum — Technical
- VIX regime is low -- calm backdrop supports risk-taking — Macro
- Market regime is bullish (Bull market -- normal position sizing) — Macro
HSIC Committee View
75% agreement
4 analysts
The primary driver is vix regime is low -- calm backdrop supports risk-taking. The main limiting factor is growth rate is decelerating quarter over quarter -- the trend line matters more than the level. The committee is constructive but not yet at full conviction.
Bull Case
- 4 consecutive earnings beats -- consistent execution — Growth
- Price structure making higher highs and higher lows — Technical
- MACD histogram positive -- bullish momentum — Technical
Bear Case
- Growth rate is decelerating quarter over quarter -- the trend line matters more than the level — Growth